NYSE:LCTX | ROA | Lineage Cell Therapeutics, Inc.

Complete source-backed roa history.

Available history
2010-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-30.37%
2026-03-31-58.62%
2025-12-31-56.43%
2025-09-30-75.48%
2025-06-30-45.06%
2025-03-31-14.50%
2024-12-31-16.44%
2024-09-30-20.82%
2024-06-30-23.53%
2024-03-31-21.81%
2023-12-31-21.27%
2023-09-30-21.73%
2023-06-30-19.72%
2023-03-31-20.81%
2022-12-31-21.25%
2022-09-30-37.29%
2022-06-30-37.27%
2022-03-31-33.69%
2021-12-31-24.65%
2021-09-30-9.14%
2021-06-30-8.85%
2021-03-31-10.68%
2020-12-31-19.13%
2020-09-30-26.35%
2020-06-30-32.04%
2020-03-31-49.98%
2019-12-31-9.33%
2019-09-30-39.24%
2019-06-3020.47%
2019-03-3130.95%
2018-12-31-45.24%
2018-09-30-41.44%
2018-06-30-111.69%
2018-03-31-120.31%
2017-12-31-11.53%
2017-09-3021.13%
2017-06-3032.98%
2017-03-3148.71%
2016-12-3123.54%
2016-09-3017.08%
2016-06-30-18.80%
2016-03-31-67.22%
2015-12-31-49.55%
2015-09-30-57.34%
2015-06-30-48.62%
2015-03-31-55.29%
2014-12-31-48.69%
2014-09-30-81.75%
2014-06-30-70.07%
2014-03-31-76.38%
2013-12-31-76.02%
2013-09-30-98.23%
2013-06-30-65.83%
2013-03-31-68.47%
2012-12-31-72.02%
2012-09-30-63.12%
2012-06-30-50.88%
2012-03-31-47.08%
2011-12-31-36.52%
2011-09-30-28.20%
2011-06-30-28.58%

Annual ROA

DateROA
2025-12-31-56.43%
2024-12-31-16.44%
2023-12-31-21.27%
2022-12-31-21.25%
2021-12-31-24.65%
2020-12-31-19.13%
2019-12-31-9.33%
2018-12-31-45.24%
2017-12-31-11.53%
2016-12-3123.55%
2015-12-31-49.64%
2014-12-31-48.61%
2013-12-31-76.01%
2012-12-31-72.02%
2011-12-31-36.04%
2010-12-31-21.00%